VIM and renal cell carcinoma: Depletion of CAPN2 could inhibit the expression of N-cadherin, vimentin and MMP9, and overexpression of CAPN2 could enhance N-cadherin, vimentin and MMP9 protein levels in renal cell carcinoma (32).